Zimmer Biomet Announces Appointment of Devdatt Kurdikar to Board of Directors [Yahoo! Finance]
Embecta Corp. (EMBC)
Company Research
Source: Yahoo! Finance
that Devdatt "Dev" Kurdikar, President, Chief Executive Officer and a member of the board of directors of Embecta Corp. (embecta), has been appointed to the Zimmer Biomet Board, effective immediately. embecta (Nasdaq: EMBC), formerly part of Becton, Dickinson and Company (BD), is one of the largest pure-play diabetes management companies in the world. "We are pleased to welcome Dev to the ZB Board," said Chris Begley, Chairman of the Company's Board of Directors. "Dev brings a wealth of medtech, innovation and leadership experience that will be invaluable to ZB as we further advance our strategic priorities and mission to alleviate pain and improve peoples' lives." Mr. Kurdikar has served as the President and Chief Executive Officer and a member of the board of directors of embecta since its spinoff from BD on April 1, 2022 . He was the Worldwide President of Diabetes Care at BD from 2021 until the spinoff. Prior to joining BD, Mr. Kurdikar was President and CEO of Cardiac Science
Show less
Read more
Impact Snapshot
Event Time:
EMBC
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
EMBC alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
EMBC alerts
High impacting Embecta Corp. news events
Weekly update
A roundup of the hottest topics
EMBC
News
- embecta-sponsored Abstracts Presented at American Diabetes Association’s 84th Scientific Sessions Highlight Unmet Need for Patch Pumps with 300u Insulin ReservoirGlobeNewswire
- Why Embecta Corp. (NASDAQ:EMBC) Could Be Worth Watching [Yahoo! Finance]Yahoo! Finance
- Embecta Corp. (NASDAQ:EMBC) Q2 2024 Earnings Call Transcript [Yahoo! Finance]Yahoo! Finance
- Embecta (NASDAQ:EMBC) Has Affirmed Its Dividend Of $0.15 [Yahoo! Finance]Yahoo! Finance
- Embecta Corp. (NASDAQ: EMBC) had its price target lowered by analysts at Morgan Stanley from $16.00 to $13.00. They now have an "underweight" rating on the stock.MarketBeat
EMBC
Earnings
- 5/9/24 - Beat
EMBC
Sec Filings
- 5/28/24 - Form SD
- 5/14/24 - Form 4
- 5/9/24 - Form S-8
- EMBC's page on the SEC website